GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Price-to-Free-Cash-Flow

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Price-to-Free-Cash-Flow : 2.90 (As of May. 25, 2024)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Price-to-Free-Cash-Flow?

As of today (2024-05-25), GlaxoSmithKline Consumer Nigeria's share price is ₦17.00. GlaxoSmithKline Consumer Nigeria's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was ₦5.86. Hence, GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow Ratio for today is 2.90.

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow or its related term are showing as below:

NSA:GLAXOSMITH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.83   Med: 3.42   Max: 966.67
Current: 2.9

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest Price-to-Free-Cash-Flow Ratio was 966.67. The lowest was 0.83. And the median was 3.42.

NSA:GLAXOSMITH's Price-to-Free-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 23.77 vs NSA:GLAXOSMITH: 2.90

GlaxoSmithKline Consumer Nigeria's Free Cash Flow per Share for the three months ended in Jun. 2023 was ₦0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₦5.86.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 292.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 159.50% per year.

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest 3-Year average Free Cash Flow per Share Growth Rate was 159.50% per year. The lowest was -35.90% per year. And the median was 37.40% per year.


GlaxoSmithKline Consumer Nigeria Price-to-Free-Cash-Flow Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Price-to-Free-Cash-Flow Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 17.94 0.87 48.77 1.03

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.15 3.61 0.86 1.03 1.32

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow falls into.



GlaxoSmithKline Consumer Nigeria Price-to-Free-Cash-Flow Calculation

GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=17.00/5.862
=2.90

GlaxoSmithKline Consumer Nigeria's Share Price of today is ₦17.00.
GlaxoSmithKline Consumer Nigeria's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦5.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


GlaxoSmithKline Consumer Nigeria Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines